Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.5%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a Phase 1/2 study evaluating FT-2102 for various advanced solid tumors and gliomas, and the addition of new cohort classifications for the study. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
- Check31 days agoChange DetectedThe web page has been updated to a new version, v2.14.4, replacing the previous version v2.14.3.SummaryDifference0.3%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.4%
- Check45 days agoChange DetectedDifference0.5%
Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.